News – Page 919 – Endpoints News

BioNTech partners with Bill and Melinda Gates Foundation, scoring $55M equity investment; BeiGene brushes off short ...

6 years ago

Randy Schatzman jumps to the helm of another start-up; Novo Nordisk vet lands top post at Macrophage Pharma

6 years ago

Stephen Hahn, 'clear frontrunner' for FDA commish job, has met with Trump — reports

6 years ago

Genentech reaches settlement with Taiwanese biotech accused of stealing trade secrets — but will keep suing ...

6 years ago

Roche boosts cancer approvals in Europe, pushing for a bigger slice of the I/O pie

6 years ago

Roivant's Vivek Ramaswamy is closing in on a $3B cash deal to sell control of 5 Vants — plus — to Sumitomo ...

6 years ago

Private equity meets China biotech: PAG infuses $540M to gain control of Hisun's biosimilar subsidiary

6 years ago

Global Blood Therapeutics buoyed by good news from FDA; Cigna to help cover pricey therapies

6 years ago

The 'mind-blowing' R&D renaissance in psychedelic meds finds a home at Johns Hopkins

6 years ago

How much has the cancer R&D frenzy translated into drug approvals? A lot

6 years ago

A battered Zafgen seeks strategic options, prophesying ongoing study will unlikely lift FDA hold on diabetes drug

6 years ago

Strike three: Bristol-Myers’ third I/O shot at glioblastoma misses as Opdivo flops yet again on key endpoint

6 years ago

Struggling poo-testing startup uBiome files for bankruptcy, months after FBI kicks off investigation

6 years ago

Mallinckrodt preps a possible bankruptcy amid a maelstrom of opioid claims — report

6 years ago

The IFM team sets up a three-peat as Novartis funds cGAS/STING program — with $840M option to buy

6 years ago

Ned Sharpless in final running for FDA commish with MD Anderson exec and Harvard prof — reports

6 years ago

The pharma industry's rep hits absolute. rock. bottom.

6 years ago

Plotting clinical entry, James Wilson's gene therapy startup brings in billionaire for $110M Series B

6 years ago

Bristol-Myers is scouting new company startups; AbbVie and Idera team up to evaluate combination for HNSCC

6 years ago

Versant-backed precision oncology startup Repare Therapeutics scores $82M+ in latest round

6 years ago

Ex-FDA chiefs, non-profits take Ned Sharpless' corner as clock ticks down on Trump's pick

6 years ago

Korean biopharma executive indicted for allegedly conducting illegal trials on company researchers

6 years ago

Vertex buys the top spot on the list of the biggest preclinical M&A deals. Were they robbed or was it a steal?

6 years ago

Co-founded by Versant, NEA investors, new medtech VC firm kicks off inaugural fund with $225M bounty

6 years ago

First page Previous page 916 917 918919920 921 922 Next page Last page